EPB41L3 has been regarded as a tumor suppressor that inhibits the progression and development of several types of cancer, including lung adenocarcinoma, meningioma, breast cancer, ovarian cancer, and prostate cancer [25,26]. This evidence concerns the gene EPB41L3 and neoplasm.